The first total synthesis of potent human chymase inhibitor SPF32629B via regioselective bromination and O-acylation strategy

Palladium-Catalyzed C6-Selective C–H Acylation of 2-Pyridones

A versatile palladium-catalyzed C6-selective C–H acylation of 2-pyridones with commercially available aldehydes using TBHP as an oxidant has been developed. This protocol tolerated diverse functional groups and has excellent level of site selectivity. Moreover, it does not require silver salts as additives.

SPF32629A and SPF32629B: enantioselective synthesis, determination of absolute configuration, cytotoxicity and antibacterial evaluation

We report herein an efficient enantioselective synthesis of SPF32629A and SPF32629B through one-pot enantioselective reduction and protecting-group-free regioselective O-acylation strategy. The absolute configuration of the enantiomerically pure isomers was established by Mosher ester analysis. The inhibitory potencies of the synthesized compounds were assayed in vitro against a panel of microorganisms and against A549 human lung adenocarcinoma cell line. Compounds 2, 11 and 12 displayed moderate to potent antibacterial activity against all the tested strains and compounds 7, 8, 2, 11 and 12 exhibited significant cytotoxicity in a dose-dependent manner with an IC50 values ranging from 2.92 to 4.14 μg/ml and 8-11 μM.